eFFECTOR Therapeutics (EFTRW) News Today → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free EFTRW Stock Alerts $0.02 +0.00 (+15.00%) (As of 11:00 AM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinemarketbeat.com - April 4 at 8:29 AMeFFECTOR Therapeutics to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conferencefinance.yahoo.com - February 5 at 8:33 AMeFFECTOR Therapeutics Inc. Warrantthestreet.com - February 4 at 2:46 PMmarketbeat.com - January 12 at 6:00 AMeFFECTOR Therapeutics Announces Reverse Stock Splitfinance.yahoo.com - January 9 at 10:10 AMeFFECTOR Therapeutics to Host Virtual Investor R&D Day on January 24, 2024finance.yahoo.com - January 9 at 10:10 AMeFFECTOR updates Phase 1/2 data for breast cancer therapyseekingalpha.com - December 8 at 12:23 PMBuy Rating for eFFECTOR Therapeutics Backed by FDA Fast Track and Promising Clinical Datamarkets.businessinsider.com - December 2 at 7:56 AMeFFECTOR Therapeutics 10% owner SR One Capital Management discloses sale of 609,163 sharesmsn.com - November 30 at 1:40 PMeFFECTOR Receives U.S. FDA Fast Track Designation for Zotatifin in Combination with Fulvestrant and Abemaciclib for Treatment of ER+/HER2- Advanced Metastatic Breast Cancerfinance.yahoo.com - November 28 at 8:10 AMeFFECTOR Therapeutics, Inc.: eFFECTOR Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Updatefinanznachrichten.de - November 27 at 9:32 AMeFFECTOR Therapeutics Stock (NASDAQ:EFTR), Analyst Ratings, Price Targets, Predictionsbenzinga.com - November 24 at 8:29 AMeFFECTOR Therapeutics Stock (NASDAQ:EFTR) Dividends: History, Yield and Datesbenzinga.com - November 24 at 8:29 AMeFFECTOR Therapeutics Inc.thestreet.com - November 19 at 8:10 AMeFFECTOR to Present New Clinical Data from Dose Escalation and Phase 2 Expansion Cohorts of Zotatifin in Patients with ER+ Metastatic Breast Cancer at SABCS 2023 Annual Meetingfinance.yahoo.com - November 15 at 8:15 AMeFFECTOR Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - November 13 at 6:19 PMeFFECTOR Therapeutics to Participate in Fireside Chat at 2023 Stifel Healthcare Conferencefinance.yahoo.com - November 6 at 10:03 AMeFFECTOR Therapeutics to Collaborate with the Northwestern University Division of Hematology and Oncology on an Investigator-Initiated Phase 1 Dose Escalation Trial Evaluating Tomivosertib in Patients with Acute Myeloid Leukemiafinance.yahoo.com - October 24 at 10:31 AM Get eFFECTOR Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EFTRW and its competitors with MarketBeat's FREE daily newsletter. Email Address At first glance, this chart looks like nonsense… (Ad)We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates” But if you want the stock with “Hotspot Dates” hitting NEXT WEEK… EFTRW Media Mentions By Week EFTRW Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EFTRW News Sentiment▼0.000.46▲Average Medical News Sentiment EFTRW News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EFTRW Articles This Week▼00▲EFTRW Articles Average Week Get eFFECTOR Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EFTRW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: DRTSW News ARTLW News BCTXW News FBIOP News GOVXW News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EFTRW) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding eFFECTOR Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
